Home/Filings/4/0000899140-25-000405
4//SEC Filing

DENNER ALEXANDER J 4

Accession 0000899140-25-000405

CIK 0001080014other

Filed

Mar 5, 7:00 PM ET

Accepted

Mar 6, 9:30 PM ET

Size

12.3 KB

Accession

0000899140-25-000405

Insider Transaction Report

Form 4
Period: 2025-03-04
Transactions
  • Sale

    Common Stock, par value $0.01 per share

    2025-03-04$17.63/sh151,175$2,665,0797,125,825 total(indirect: See footnotes)
  • Sale

    Common Stock, par value $0.01 per share

    2025-03-06$17.52/sh1,196,746$20,964,2375,658,705 total(indirect: See footnotes)
  • Sale

    Common Stock, par value $0.01 per share

    2025-03-05$17.63/sh270,374$4,766,1266,855,451 total(indirect: See footnotes)
Transactions
  • Sale

    Common Stock, par value $0.01 per share

    2025-03-04$17.63/sh151,175$2,665,0797,125,825 total(indirect: See footnotes)
  • Sale

    Common Stock, par value $0.01 per share

    2025-03-05$17.63/sh270,374$4,766,1266,855,451 total(indirect: See footnotes)
  • Sale

    Common Stock, par value $0.01 per share

    2025-03-06$17.52/sh1,196,746$20,964,2375,658,705 total(indirect: See footnotes)
Footnotes (5)
  • [F1]On March 4, 2025, the Reporting Persons sold 151,175 shares of Common Stock at a weighted average price of $17.6291 per share. The shares were sold in multiple open market transactions at prices ranging from $17.55 to $17.89 per share, inclusive. The Reporting Persons undertake to provide, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
  • [F2]On March 5, 2025, the Reporting Persons sold 270,374 shares of Common Stock at a weighted average price of $17.6279 per share. The shares were sold in multiple open market transactions at prices ranging from $17.49 to $17.72 per share, inclusive. The Reporting Persons undertake to provide, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
  • [F3]On March 6, 2025, the Reporting Persons sold 1,196,746 shares of Common Stock at a weighted average price of $17.5177 per share. The shares were sold in multiple open market transactions at prices ranging from $17.48 to $17.64 per share, inclusive. The Reporting Persons undertake to provide, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
  • [F4]Sarissa Capital Management LP ("Sarissa Capital") is the investment advisor to Sarissa Capital Offshore Master Fund LP, Sarissa Capital Catapult Fund LLC, Sarissa Capital Hawkeye Fund LP and Sarissa Capital Master Fund II LP (collectively, the "Sarissa Funds") and may be deemed to beneficially own the shares of Common Stock directly beneficially owned by the Sarissa Funds by virtue of the authority granted to it to vote and to dispose of the securities held by them, including the shares of Common Stock. Alexander J. Denner, Ph.D., a citizen of the United States of America ("Dr. Denner"), is the Chief Investment Officer and ultimate general partner of Sarissa Capital and is the ultimate general partner, or controls the managing member, of each of the Sarissa Funds; accordingly, Dr. Denner may be deemed to beneficially own the shares of Common Stock directly held by the Sarissa Funds by virtue of such positions.
  • [F5]Each of Dr. Denner, Sarissa Capital and each of the Sarissa Funds disclaims beneficial ownership of the shares of Common Stock reported herein except, in each case, to the extent of their pecuniary interest therein.

Documents

1 file

Issuer

Innoviva, Inc.

CIK 0001080014

Entity typeother

Related Parties

1
  • filerCIK 0001361754

Filing Metadata

Form type
4
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 9:30 PM ET
Size
12.3 KB